Pharma companies in India — 3000+
But
70% of Revenue is captured by 26 companies
Voila, Pareto Principle
Top 5 companies
Sun Pharma
Abbott India
Cipla
Mankind Pharma
Zydus Cadila
Total Covid related drug sales in India by top 26 (anti-virals, antibiotics, vitamins & supplements) — $570 million
Total non-covid drug sales of just Zydus — $840 million
Covid drugs are a minuscule fraction of Pharma company sales
Despite actual sales being sluggish, the stocks of these companies more than doubled
Thanks to “market sentiment”
Total Sales of covid drugs
Remdesivir — Rs 470 Crore
Favipiravir — Rs 450 crore
Hydroxychloroquine(HCQ) — Rs 210 crore
Price/unit
Remdesivir — Rs 2800–5400
Favipiravir — Rs 32–69
HCQ- Rs 5–13
IPCA Labs sold 84% of all HCQ tablets
Glenmark sold $46 million of Fabiflu
Cost per unit Rs 100
Patient is required to consume 66 tablets/week
Sale of steroids to treat inflammation & blood thinners
Dexamethasone- $18 million
Cost per unit — Rs 7–19
With the rise of covid drug sales, anti-cancer focused companies like Novartis took a huge hit
Sex stimulant sales went down to -6%
